LOVFF (Cannara Biotech) Interest Expense: $-2.06 Mil (TTM As of Feb. 2026)

What is Cannara Biotech Interest Expense?

Cannara Biotech LOVFF +5.93% 86 Interest Expense is $-2.06 Mil as of Feb. 2026. GuruFocus rates LOVFF with a GF Score™ of 86/100 and a GF Value™ of $1.17 (Fairly Valued). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cannara Biotech's interest expense for the three months ended in Feb. 2026 was $ -0.37 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2026 was $-2.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cannara Biotech's Operating Income for the three months ended in Feb. 2026 was $ 2.49 Mil. Cannara Biotech's Interest Expense for the three months ended in Feb. 2026 was $ -0.37 Mil. Cannara Biotech's Interest Coverage for the quarter that ended in Feb. 2026 was 6.83. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cannara Biotech (OTCPK:LOVFF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cannara Biotech's Interest Expense for the three months ended in Feb. 2026 was $-0.37 Mil. Its Operating Income for the three months ended in Feb. 2026 was $2.49 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2026 was $18.48 Mil.

Cannara Biotech's Interest Coverage for the quarter that ended in Feb. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Feb. 2026 )	/	Interest Expense (Q: Feb. 2026 )
	=	-1	*	2.492	/	-0.365
	=	6.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cannara Biotech Interest Expense Historical Data

* Premium members only.

The historical data trend for Cannara Biotech's Interest Expense can be seen below:

Cannara Biotech Interest Expense Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Aug25

Interest Expense

Get a 7-Day Free Trial

-1.36

-2.16

-3.36

-3.55

-2.73

Cannara Biotech Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
Interest Expense	Get a 7-Day Free Trial															-0.71	-0.68	-0.58	-0.43	-0.37

86GF Score

Cannara Biotech Inc LOVFF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cannara Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.06 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-2.06 Mil mean?

Cannara Biotech (LOVFF) has a Interest Expense of $-2.06 Mil as of Feb. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cannara Biotech and its competitors.

Is Cannara Biotech's Interest Expense too high?

Cannara Biotech's current Interest Expense is $-2.06 Mil. Overall, Cannara Biotech has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Cannara Biotech's Interest Expense compare to ZTS and UTHR?

Cannara Biotech's Interest Expense of $-2.06 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cannara Biotech and its competitors. Cannara Biotech's current Interest Expense is $-2.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cannara Biotech stock overvalued right now?

Based on GuruFocus' analysis, Cannara Biotech (LOVFF) is currently considered Fairly Valued. The stock's GF Value™ is $1.17, compared to a current price of $1.25 — trading 6.8% above its estimated fair value. The current Interest Expense is $-2.06 Mil. Cannara Biotech's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Cannara Biotech (LOVFF), the current Interest Expense is $-2.06 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannara Biotech (LOVFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be overvalued. The current stock price of $1.25 is trading 6.8% above its estimated GF Value™ of $1.17. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for LOVFF:

Interest Expense: $-2.06 Mil
GF Value™: $1.17 vs. price of $1.25 (6.8% above fair value)
GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the LOVFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSXV:RX TSX:CRDL XCNQ:GRIN XCNQ:AAWH.U XCNQ:JUSH TSX:MDP TSX:HLS TSX:OGI TSX:CWEB XCNQ:NVRS XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 8CB0:Germany LOVE:Canada

Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

86GF Score

Get the complete analysis for LOVFF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25

Price

$1.17

GF Value

View LOVFF Analysis

See Interest Expense data for all stocks →